Sci Rep 10(1):12510 Rehman HU, Alharby HF, Bamagoos AA, Abdelhamid MT, Rady MM (2021) Sequenced application of glutathione as an antioxidant with an organic biostimulant improves physiological and metabolic adaptation to salinity in wheat
The condition can also cause migraine-like neurological symptoms such as well as dizziness or vertigo
Show Sources Photo Credit: Moment/Getty Images SOURCES: Cleveland Clinic: GLP-1 Agonists, Dehydration, Ozempic Face: What It Is and How To Avoid It, Elastin, Sebaceous Glands, Telogen Effluvium, Can Ozempic Cause Hair Loss? What the SPF in Your Sunscreen Means, Best Ingredients and Products for Your Anti-Aging Skin Care Routine, Subcutaneous Fat. Clinical, Cosmetic and Investigational Dermatology: Dietary water affects human skin hydration and biomechanics. NIH Diseases: A Closer Look at the Dermatological Profile of GLP-1 Agonists. NIH Endocrine: GLP-1RA and the possible skin aging. George Washington University: Media Tip Sheet: The Impact GLP-1 Drugs Have on Your Skin, Study Links Popular GLP-1 Weight-Loss Drugs to Increased Risk of Hair Loss. UCLA Health: Ozempic face (and other GLP-1 side effects). Journal of Clinical and Aesthetic Dermatology: A Review of Glucagon-like Peptide-1 in Dermatology. Harvard Health: GLP-1 diabetes and weight-loss drug side effects: Ozempic face and more. JAMA Internal Medicine Patient Page: I Am Taking a GLP-1 Weight-Loss MedicationWhat Should I Know? American Journal of Physiology Regulatory, Integrative and Comparative Physiology: Glucagon-like peptide-1 receptor agonists suppress water intake independent of effects on food intake. Mayo Clinic: Psoriasis. Journal of Cellular Signaling: A Discussion on the Relationship between Skin Lipid Metabolism and Whole-Body Glucose and Lipid Metabolism: Systematic Review. Cureus: Hair Loss Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Use: A Systematic Review. JAAD International: Increased Incidence and Risk of Hair Loss with GLP-1 Receptor Agonists: A RealWorld Multicenter TrinetX Cohort Study. American Academy of Dermatology Association: "Dermatologists' Top Tips for Relieving Dry Skin.
Instead, if FDA adopts the recommendations, eligible 503A pharmacies could compound patient-specific medications using the peptides pursuant to valid prescriptions, consistent with the requirements of the Federal Food, Drug, and Cosmetic Act (FD&C Act)
Because its a stimulant, the phentermine label warns about increases in blood pressure, insomnia if taken late in the day, and its contraindicated in people with a history of cardiovascular disease, uncontrolled hypertension, hyperthyroidism, glaucoma, agitated states, or a history of drug abuse
